These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28922167)

  • 1. Statins and Cognition in Parkinson's Disease.
    Deck BL; Rick J; Xie SX; Chen-Plotkin A; Duda JE; Morley JF; Chahine LM; Dahodwala N; Trojanowski JQ; Weintraub D
    J Parkinsons Dis; 2017; 7(4):661-667. PubMed ID: 28922167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts.
    Swallow DM; Lawton MA; Grosset KA; Malek N; Klein J; Baig F; Ruffmann C; Bajaj NP; Barker RA; Ben-Shlomo Y; Burn DJ; Foltynie T; Morris HR; Williams N; Wood NW; Hu MT; Grosset DG
    J Neurol Neurosurg Psychiatry; 2016 Nov; 87(11):1183-1190. PubMed ID: 27671901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease.
    Ong M; Foo H; Chander RJ; Wen MC; Au WL; Sitoh YY; Tan L; Kandiah N
    J Neurol Sci; 2017 Jun; 377():122-126. PubMed ID: 28477681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins, risk of dementia, and cognitive function: secondary analysis of the ginkgo evaluation of memory study.
    Bettermann K; Arnold AM; Williamson J; Rapp S; Sink K; Toole JF; Carlson MC; Yasar S; Dekosky S; Burke GL
    J Stroke Cerebrovasc Dis; 2012 Aug; 21(6):436-44. PubMed ID: 21236699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of statins on dopamine loss and prognosis in Parkinson's disease.
    Jeong SH; Lee HS; Chung SJ; Yoo HS; Jung JH; Baik K; Lee YH; Sohn YH; Lee PH
    Brain; 2021 Nov; 144(10):3191-3200. PubMed ID: 34347020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes on brief cognitive instruments over time in Parkinson's disease.
    Lessig S; Nie D; Xu R; Corey-Bloom J
    Mov Disord; 2012 Aug; 27(9):1125-8. PubMed ID: 22692724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson's disease.
    Kandiah N; Zhang A; Cenina AR; Au WL; Nadkarni N; Tan LC
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1145-8. PubMed ID: 25176439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term cognitive follow-up of Parkinson's disease patients with impulse control disorders.
    Siri C; Cilia R; Reali E; Pozzi B; Cereda E; Colombo A; Meucci N; Canesi M; Zecchinelli AL; Tesei S; Mariani CB; Sacilotto G; Zini M; Pezzoli G
    Mov Disord; 2015 Apr; 30(5):696-704. PubMed ID: 25757654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computerized testing in Parkinson's disease: Performance deficits in relation to standard clinical measures.
    Flannery SL; Jowett T; Garvey A; Cutfield NJ; Machado L
    J Clin Exp Neuropsychol; 2018 Dec; 40(10):1062-1073. PubMed ID: 29978753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score.
    Nazem S; Siderowf AD; Duda JE; Have TT; Colcher A; Horn SS; Moberg PJ; Wilkinson JR; Hurtig HI; Stern MB; Weintraub D
    J Am Geriatr Soc; 2009 Feb; 57(2):304-8. PubMed ID: 19170786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uric acid and cognition in Parkinson's disease: a follow-up study.
    Annanmaki T; Pohja M; Parviainen T; Hakkinen P; Murros K
    Parkinsonism Relat Disord; 2011 Jun; 17(5):333-7. PubMed ID: 21320793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term cognitive outcome of bilateral subthalamic deep brain stimulation in Parkinson's disease.
    Kim HJ; Jeon BS; Paek SH; Lee KM; Kim JY; Lee JY; Kim HJ; Yun JY; Kim YE; Yang HJ; Ehm G
    J Neurol; 2014 Jun; 261(6):1090-6. PubMed ID: 24687897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homocysteine and cognitive function in Parkinson's disease.
    Licking N; Murchison C; Cholerton B; Zabetian CP; Hu SC; Montine TJ; Peterson-Hiller AL; Chung KA; Edwards K; Leverenz JB; Quinn JF
    Parkinsonism Relat Disord; 2017 Nov; 44():1-5. PubMed ID: 28807493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of circulatory BDNF with cognitive deficits in people with Parkinson's disease.
    Khalil H; Alomari MA; Khabour OF; Al-Hieshan A; Bajwa JA
    J Neurol Sci; 2016 Mar; 362():217-20. PubMed ID: 26944151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting cognitive decline with non-clinical markers in Parkinson's disease (PRECODE-2).
    Yousaf T; Pagano G; Niccolini F; Politis M
    J Neurol; 2019 May; 266(5):1203-1210. PubMed ID: 30820739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal changes in cognition in Parkinson's disease with and without dementia.
    Johnson DK; Galvin JE
    Dement Geriatr Cogn Disord; 2011; 31(2):98-108. PubMed ID: 21242691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins and cognitive decline in older adults with normal cognition or mild cognitive impairment.
    Steenland K; Zhao L; Goldstein FC; Levey AI
    J Am Geriatr Soc; 2013 Sep; 61(9):1449-55. PubMed ID: 24000778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins and cognition in late-life bipolar disorder.
    Rej S; Schulte SW; Rajji TK; Gildengers AG; Miranda D; Menon M; Butters MA; Mulsant BH
    Int J Geriatr Psychiatry; 2018 Oct; 33(10):1355-1360. PubMed ID: 30022520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A longitudinal study of neuropsychological change in individuals with Parkinson's disease.
    Azuma T; Cruz RF; Bayles KA; Tomoeda CK; Montgomery EB
    Int J Geriatr Psychiatry; 2003 Dec; 18(12):1115-20. PubMed ID: 14677144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study.
    Schrag A; Siddiqui UF; Anastasiou Z; Weintraub D; Schott JM
    Lancet Neurol; 2017 Jan; 16(1):66-75. PubMed ID: 27866858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.